Open-Label Study of Dexmethylphenidate Hydrochloride in Children and Adolescents with Attention Deficit Hyperactivity Disorder
- 1 December 2004
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in Journal of Child and Adolescent Psychopharmacology
- Vol. 14 (4), 555-563
- https://doi.org/10.1089/cap.2004.14.555
Abstract
Background: This pilot study examined the efficacy and duration of the effect of dexmethylphenidate (d-MPH) given once-daily in subjects with attention deficit hyperactivity disorder (ADHD). Method: Subjects aged 6–18 years (inclusive) with ADHD were enrolled in this 8-week, openlabel study. Outcome measures included the Conners'Teacher and Parent Rating Scales, the Attention Deficit Disorder Rating Scale (ADDRS), the Clinical Global Impression (CGI) Scale, and teacher and parent visual analog scales to estimate the duration of efficacy. d-MPH was initiated at a dose of 2.5 mg/day. The dose was flexible, based on response and tolerability, and could be increased in increments of 2.5 mg/day to a maximum daily dose of 30 mg/day. Results: Twenty-two subjects (mean age, 8.7 ± 0.4 years) were treated. Significant improvements (p < 0.0001) from baseline occurred in the Conners' Teacher and Parent Rating Scales after 8 weeks. Of the evaluated subjects, 85.7% (18 of 21) showed at least a 30% improvement from baseline on the Conners' Teacher Rating Scale, and 86.4% (19 of 22) of subjects showed at least a 30% improvement from baseline on the Conners' Parent Rating Scale. Most subjects demonstrated an improvement on the ADDRS and the CGI—Improvement (CGI-I) scale. Median duration of effect was estimated at 6.2 hours (teachers) and at 7.5 hours (parents). On average, patients gained 2.4 pounds over the course of the study. Conclusions: A single daily dose of d-MPH was effective in controlling ADHD in children and was well tolerated. Future studies are needed to confirm these findings and to evaluate chronic dosing with d-MPH.Keywords
This publication has 6 references indexed in Scilit:
- A Double-Blind, Placebo-Controlled Trial of Dexmethylphenidate Hydrochloride and d,l-threo-Methylphenidate Hydrochloride in Children With Attention-Deficit/Hyperactivity DisorderJournal of the American Academy of Child & Adolescent Psychiatry, 2004
- Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children*Clinical Pharmacology & Therapeutics, 1999
- Prevalence and Risk Factors of Behavioral and Emotional Problems Among Chinese Children Aged 6 Through 11 YearsJournal of the American Academy of Child & Adolescent Psychiatry, 1999
- Chiral drugs: comparison of the pharmacokinetics of [ 11 C] d-threo and l-threo -methylphenidate in the human and baboon brainPsychopharmacology, 1997
- Toward a New Psychometric Definition of Social Disability in Children with Attention-Deficit Hyperactivity DisorderJournal of the American Academy of Child & Adolescent Psychiatry, 1996
- Enantioselective pharmacokinetics and pharmacodynamics of dl-thero-mcthylphenidate in children with attention deficit hyperactivity disorderClinical Pharmacology & Therapeutics, 1992